About this trial
Neurovascular complications can result from this procedure usually from thromboembolism from the operated vessel, cerebral hypoperfusion causing ischaemia and, rarely, intracerebral haemorrhage. The overall incidence of perioperative strokes complicating CEA is approximately 4% ,and represents a devastating outcome that the procedure was designed to prevent. Other neurological sequelae complicating carotid revascularisation include cerebral hyperperfusion syndrome, cranial and peripheral nerve injuries, and contrast encephalopathy in patients undergoing CAS.
The aim of this study is To evaluate the safety and efficacy of carotid endarterectomy for symptomatic carotid Stenosis patients
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• Symptomatic carotid artery stenosis
Carotid artery stenosis more than 60 %
Disqualifiers
Patient with other etiology (vasculitis dissection)
Patient with mild Stenosis
Asymptomatic
Trial population
Symptomatic carotid artery stenosis with Carotid artery stenosis more than 60 %
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
rate of post operative ipsilateral stroke
rate of post operative ipsilateral stroke
mortality rate
short term mortality rate postoperative
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: